Conclusion
In the development of new neuromuscular blocking drugs the anesthesiologist is now provided with drugs that are almost free of unwanted effects, have a time course of action that allows great control of their activity and, in most cases, allow us to substitute them for succinylcholine. Muscle Relaxants are Cheap.
Conclusion
Avec le développement de nouveaux myorelaxants, l’anesthésiologiste a maintenant à sa disposition des médicaments qui sont presque sans effets secondaires, ont une durée d’action qui permet de bien contrôler leur activité et, dans la plupart des cas, permettent de les substituer à la succinylcholine. Les myorelaxants sont bon marché.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bedford RE. From the FDA. Anesthesiology 1995; 82: 33A.
Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar I. Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988; 69: 57–62.
Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993; 79: 913–8.
Hickey DR, O’Connor JP, Donati F. Comparison of atracurium and succinylcholine for electroconvulsive therapy in a patient with atypical plasma cholinesterase. Can J Anaesth 1987; 34: 280–3.
Vanlinthout LE, Bartels CF, Lockridge O, Callens K, Booij LH. Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase. Anesth Analg 1998; 87: 1199–202.
Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358–71.
Wright PMC, Brown R, Lau M, Fisher DM. A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide. Anesthesiology 1999; 90: 16–23.
Wierda JMKH, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38: 430–5.
Phringer FK, Khuenl-Brady KS, Koller J, Mitterschiffthaler G. Evaluation of the endotracheal intubating conditions of rocuronium (ORG 9426) and succinylcholine in outpatient surgery. Anesth Analg 1992; 75: 37–40.
Meistelman C, Plaud B, Donati F. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth 1992; 39: 665–9.
Mazurnk AJ, Re B, Hann S, Kim JI, Castro B, Coté CJ. Rocuronium versus succinylcholine: are they equally effective during rapid-sequence induction of anesthesia. Anesth Analg 1998; 87: 1259–62.
Savarese JJ, Ali HH, Basta SJ, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): a short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723–32.
Goudsouzian NG, Alifimoff JK, Everly C, et al. Neuromuscular and cardiovascular effects of mivacurium in children. Anesthesiology 1989; 70: 237–42.
Bevan DR, Kahwaji R, Ansermino JM, et al. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology 1996; 84: 362–7.
Savarese JJ, Ali HH, Basta SJ, et al. The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 1989; 70: 386–94.
Lepage J-Y, Malinovsky J-M, Malinge M, et al. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia. Anesth Analg 1996; 83: 823–9.
Naguib M, Samarkandi AH, Ammar A, Elfaqih SR, Al-Zahrani, Turkistani A. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology 1998; 89: 1116–24.
Kahwaji R, Bevan DR, Bikhazi G, et al. Dose-ranging study in younger adult and elderly patients of ORG 9487, a new rapid-onset, short-duration muscle relaxant Anesth Analg 1997; 84: 1011–8.
Wierda JM, van den Broek L, Proost JH, Verbaan BW, Hennis PJ. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine. Anesth Analg 1993; 77: 579–84.
Purdy R, Bevan, DR, Fowler C, Donati F, Lichtor JL. Early reversal of rapacuronium with neostigmine. Anesthesiology (accepted for publication).
Ali HH, Lien CA, Witkowski T, et al. Efficacy and safety of divided dose administration of mivacurium for a 90 second tracheal intubation. J Clin Anesth 1996; 8: 276–81.
Sieber TJ, Zbinden AM, Curatolo M, Shorten GD. Tracheal intubation with rocuronium using the “timing principle”. Anesth Analg 1996; 86: 1137–40.
Viby-Mogensen J, Jørgensen BC, Ørding H. Residual curarization in the recovery room. Anesthesiology 1979; 50: 539–41.
Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988; 69: 272–6.
Orkin FK. Moving toward value-based anesthesia care. J Clin Anesth 1993; 5: 91–8.
Kopman AA, Ng J, Zank LM, Neuman GG, Yee PS. Residual postoperative paralysis. Pancuronium versus mivacurium, does it matter? Anesthesiology 1996; 85: 1253–9.
Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Anesthesiology 1997; 87: 1045–43.
Eriksson LI, Lennmarken C, Johnson A. Attenuated ventilatory response to hypoxemia after vecuronium induced neuromuscular block. Acta Anaesthesiol Scand 1992; 36: 710–5.
Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand 1997; 41: 1095–103.
Johnstone RE, Jozefczyk KG. Costs of anesthetic drugs: experiences with a cost education trial. Anesth Analg 1994; 78: 766–71.
Lubarsky DA, Glass PSA, Ginsberg B, et al. The successful implementation of pharmaceutical practice guidelines. Anesthesiology 1997; 86: 1145–60.
Lubarsky DA, Sanderson IC, Gilbert WC, et al. Using an anesthesia information management system as a cost containment tool. Anesthesiology 1997; 86: 1161–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bevan, D.R. The new relaxants: are they worth it?. Can J Anesth 46 (Suppl 5), R88–R100 (1999). https://doi.org/10.1007/BF03013185
Issue Date:
DOI: https://doi.org/10.1007/BF03013185